Home Financial Markets Here is why RA Medical Systems Inc (RMED) stock turnaround on Wednesday?

Here is why RA Medical Systems Inc (RMED) stock turnaround on Wednesday?

Ra Medical Systems Inc. (RMED) shares gained 10.71% in the after-market on Wednesday, April 28, 2021, after losing 3.97% in the morning session to close at $4.11. RMED shares have sink 84.04% over the last 12 months, and they have moved up by 10.19% in the past week. Over the past three months, the stock has lost 41.29%, while over the past six months, it has shed 29.44%.

Let’s try to find out is there any reason behind its flipping on Wednesday?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Enrollment Update about the clinical trial of DABRA

On April 20, 2021, RA Medical Systems Inc reported an increase in enrollment in its pivotal clinical trial to assess the safety and effectiveness of the DABRA excimer laser system. As of April 19, 2021, a total of 42 patients have been enrolled.

Read More

The DABRA excimer laser system received U.S. FDA 510(k) clearance in May 2017 for crossing chronic total occlusions.

Upcoming financial results announcement

On April 19, 2021, RA Medical Systems Inc said that it will release its first-quarter 2021 financial results after market close on Tuesday, May 11, 2021.

A conference call has been organized on the same day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.

Q4 and FY-2020 financial results

The company filed its audited financial statements for the fiscal year ended December 31, 2020, on Form 10-Kwith the Securities and Exchange Commission on March 17, 2021.

Q4 2020 financial highlights

  • Q4 2020 net revenue was $1.2 million, compared with net revenue of $1.4 million for the fourth quarter of 2019.
  • Selling, general and administrative expenses were $6.9 million in Q4 2020 compared with $8.6 million for the fourth quarter of 2019.
  • Research and development expenses for the fourth quarter of 2020 were $3.4 million compared with $0.8 million for the fourth quarter of 2019.
  • RA Medical Systems suffered a net loss of 4 million, or $3.61 per share in Q4 2020 compared to a net loss of $9.7 million, or $18.04 per share in Q4 2019.
  • Adjusted EBITDA was -$8.8 million for the reported quarter, compared with negative $8.0 million for the fourth quarter of 2019.
  • As of December 31, 2020, Ra Medical had cash and cash equivalents of $23.9 million. 

FY2020 financial highlights

  • FY 2020 net revenue was $4.4 million compared with net revenue of $7.2 million for 2019.
  • Selling, general and administrative expenses were $26.0 million in FY 2020 compared with $51.5 million for 2019.
  • Research and development expenses for 2020 were $9.0 million compared with $4.5 million for 2019.
  • RA Medical Systems had a net loss of 0 million or $21.22 per share in FY 2020 compares with a net loss of $57.0 million, or $108.28 per share in 2019.
  • Adjusted EBITDA was negative $29.6 million in 2020 compared with negative $32.4 million for 2019.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

There is no recent news except an update about the DABRA patient enrollment on April 20 which we do not think so is the reason behind its turnaround on Wednesday. Also, it’s hard to predict its future performance at this moment.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Relmada Therapeutics Inc. (RLMD) stock is plunging in the current trading session; What’s going on?

In the current trading session, Relmada Therapeutics Inc. (RLMD) stock shares are plunging by -5.97%. The current trading price is at $23.62 in the...

Helix Energy Solutions Inc. (HLX) stock fell during pre-market. What’s behind this decline?

Helix Energy Solutions Group Inc. (HLX) stock gained by 4.54% at the last close whereas the HLX stock price plunged by 6.72% in the...

Here is why Range Resources Corporation (RRC) stock plummeted in the after-hours on Monday?

Range Resources Corporation (RRC) shares lost 6.50% in after-hours on Monday, July 26, 2021, and close the daily trading at $14.95. in the regular...

ATI Physical Therapy Inc. (ATIP) stock declines during current market trading. Here’s the recent development.

ATI Physical Therapy Inc. (ATIP) stock plunged by 36.45% in the current market trading session. ATI is leading the market by creating quality standards...

Meten Edtechx Ltd. (METX) stock declines during pre-market trading given no current news

Meten Edtechx Ltd. (METX) stock plunged by 29.42% at the last close while the METX stock price fell by 8.64% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam